Adrian Rawcliffe
CIK 1555851 · Chief Executive Officer · last filed 2025-12-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.04M
Companies
3
Total Filings
49
Lifetime Open-Market Net
-$2.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WVE | Director | 54,700 | $5.87 | $321.1K | -$739.4K | 12 | 2025-12-10 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Chief Executive Officer | 44,327 | $0.06 | $2.6K | -$518.7K | 30 | 2025-02-20 |
| ASND | CEO and CFO | 3,318 | $218.06 | $723.5K | -$1.04M | 7 | 2019-09-03 |
Recent Filings · Page 2 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-01 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −2,403 | -$1.9K | EDGAR |
| 2023-08-09 | WVE | Grant (A) | — | $0 | EDGAR |
| 2023-06-27 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −2,333 | -$2.1K | EDGAR |
| 2023-01-17 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-17 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −10,057 | -$18.7K | EDGAR |
| 2023-01-12 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −31,805 | -$54.8K | EDGAR |
| 2023-01-04 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −5,073 | -$8.6K | EDGAR |
| 2022-09-01 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −2,536 | -$5.0K | EDGAR |
| 2022-08-17 | WVE | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −2,562 | -$4.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.